Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein

Cellular and Molecular Life Sciences

Volumn 73, Issue 1, 2016, Pages 201-215

  Grimm, Amandine ^a,b,c   Biliouris, Emily E ^a,b   Lang, Undine E ^b   Götz, Jürgen ^d   Mensah Nyagan, Ayikoe Guy ^c   Eckert, Anne ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Amyloid peptide; Bioenergetics; Mitochondria; Neurosteroids; Tau protein

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANDROGEN RECEPTOR; ANDROSTANEDIOL; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; NEUROSTEROID; PROGESTERONE; PROGESTERONE RECEPTOR; TAU PROTEIN; TESTOSTERONE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; APP PROTEIN, HUMAN; SEX HORMONE;

ALZHEIMER DISEASE; ARTICLE; BIOENERGETIC DEFICIT; BIOENERGY; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG MECHANISM; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL BIOENERGETICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOLECULAR DYNAMICS; MOLECULAR MODEL; NEUROBLASTOMA CELL LINE; NEUROPROTECTION; PROTEIN EXPRESSION; PROTEIN HYPERPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; SH SY5Y CELL LINE; TAUOPATHY; TURNOVER TIME; WILD TYPE; CELL LINE; ENERGY METABOLISM; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; POINT MUTATION; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE; ENERGY METABOLISM; GONADAL STEROID HORMONES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEURONS; NEUROTRANSMITTER AGENTS; PHOSPHORYLATION; POINT MUTATION; TAU PROTEINS; UP-REGULATION;

EID: 84952982461     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-1988-x     Document Type: Article

References (74)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's Dement 9(1):63-75. doi: 10.1016/j.jalz.2012.11.007 e62
2. Van Dam D, De Deyn PP (2006) Drug discovery in dementia: the role of rodent models. Nat Rev Drug Discovery 5(11):956-970. doi: 10.1038/nrd2075
3. Goedert M, Jakes R (2005) Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 1739(2-3):240-250. doi: 10.1016/j.bbadis.2004.08.007
4. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8(7):499-509. doi: 10.1038/nrn2168
5. Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430(7000):631-639. doi: 10.1038/nature02621
6. Perez PD, Hall G, Kimura T, Ren Y, Bailey RM, Lewis J, Febo M, Sahara N (2013) In vivo functional brain mapping in a conditional mouse model of human tauopathy (tauP301L) reveals reduced neural activity in memory formation structures. Mol Neurodegener 8:9. doi: 10.1186/1750-1326-8-9
7. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimer's Dement 3(3):186-191. doi: 10.1016/j.jalz.2007.04.381
8. Eckert A, Schmitt K, Götz J (2011) Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-beta toxicity. Alzheimers Res Ther 3(2):15. doi: 10.1186/alzrt74
9. Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88(4):640-651. doi: 10.1016/j.bcp.2013.12.024
10. Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Götz J, Eckert A (2012) Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio. Antioxid Redox Signal 16(12):1456-1466. doi: 10.1089/ars.2011.4400
11. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60(5):748-766. doi: 10.1016/j.neuron.2008.10.010
12. Scheffler IE (2001) A century of mitochondrial research: achievements and perspectives. Mitochondrion 1(1):3-31. pii: S1567-7249(00)00002-7
13. Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105(8-9):855-870
14. Manczak M, Park BS, Jung Y, Reddy PH (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 5(2):147-162. doi: 10.1385/NMM:5:2:147
15. Swerdlow RH, Burns JM, Khan SM (2014) The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta 1842(8):1219-1231. doi: 10.1016/j.bbadis.2013.09.010
16. Mosconi L, Pupi A, De Leon MJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci 1147:180-195. doi: 10.1196/annals.1427.007
17. Chen S, Wang JM, Irwin RW, Yao J, Liu L, Brinton RD (2011) Allopregnanolone promotes regeneration and reduces beta-amyloid burden in a preclinical model of Alzheimer's disease. PLoS One 6(8):e24293. doi: 10.1371/journal.pone.0024293
18. Grimm A, Lim YA, Mensah-Nyagan AG, Götz J, Eckert A (2012) Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship. Mol Neurobiol 46(1):151-160. doi: 10.1007/s12035-012-8281-x
19. Grimm A, Schmitt K, Lang UE, Mensah-Nyagan AG, Eckert A (2014) Improvement of neuronal bioenergetics by neurosteroids: Implications for age-related neurodegenerative disorders. Biochim Biophys Acta. doi: 10.1016/j.bbadis.2014.09.013
20. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci U S A 78(8):4704-4707
21. Mensah-Nyagan AG, Do-Rego JL, Beaujean D, Luu-The V, Pelletier G, Vaudry H (1999) Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev 51(1):63-81
22. Panzica GC, Balthazart J, Frye CA, Garcia-Segura LM, Herbison AE, Mensah-Nyagan AG, McCarthy MM, Melcangi RC (2012) Milestones on steroids and the nervous system: 10 years of basic and translational research. J Neuroendocrinol 24(1):1-15. doi: 10.1111/j.1365-2826.2011.02265.x
23. Patte-Mensah C, Kibaly C, Boudard D, Schaeffer V, Begle A, Saredi S, Meyer L, Mensah-Nyagan AG (2006) Neurogenic pain and steroid synthesis in the spinal cord. J Mol Neurosci 28(1):17-31. doi: 10.1385/JMN:30:3:341
24. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A, Suter U, Carelli C, Baulieu EE, Akwa Y (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71(1):3-29. pii: S0301008203001576
25. Melcangi RC, Garcia-Segura LM, Mensah-Nyagan AG (2008) Neuroactive steroids: state of the art and new perspectives. Cellular Mol Life Sci 65(5):777-797. doi: 10.1007/s00018-007-7403-5
26. Rhein V, Baysang G, Rao S, Meier F, Bonert A, Muller-Spahn F, Eckert A (2009) Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells. Cell Mol Neurobiol 29(6-7):1063-1071. doi: 10.1007/s10571-009-9398-y
27. Schulz KL, Eckert A, Rhein V, Mai S, Haase W, Reichert AS, Jendrach M, Muller WE, Leuner K (2012) A new link to mitochondrial impairment in tauopathies. Mol Neurobiol 46(1):205-216. doi: 10.1007/s12035-012-8308-3
28. Grassi D, Bellini MJ, Acaz-Fonseca E, Panzica G, Garcia-Segura LM (2013) Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-alpha and -beta. Endocrinology 154(6):2092-2100. doi: 10.1210/en.2012-2137
29. Takahashi K, Piao S, Yamatani H, Du B, Yin L, Ohta T, Kawagoe J, Takata K, Tsutsumi S, Kurachi H (2011) Estrogen induces neurite outgrowth via Rho family GTPases in neuroblastoma cells. Molecular Cell Neurosci 48(3):217-224. doi: 10.1016/j.mcn.2011.08.002
30. Scheuermann S, Hambsch B, Hesse L, Stumm J, Schmidt C, Beher D, Bayer TA, Beyreuther K, Multhaup G (2001) Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease. J Biol Chem 276(36):33923-33929. doi: 10.1074/jbc.M105410200
31. Rhein V, Giese M, Baysang G, Meier F, Rao S, Schulz KL, Hamburger M, Eckert A (2010) Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure. PLoS One 5(8):e12359. doi: 10.1371/journal.pone.0012359
32. Ferrari A, Hoerndli F, Baechi T, Nitsch RM, Götz J (2003) beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem 278(41):40162-40168. doi: 10.1074/jbc.M308243200
33. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Muller-Spahn F, Haass C, Czech C, Pradier L, Muller WE, Eckert A (2004) Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279(48):50310-50320. doi: 10.1074/jbc.M405600200
34. Götz J, Eckert A, Matamales M, Ittner LM, Liu X (2011) Modes of Abeta toxicity in Alzheimer's disease. Cellular Mol Life Sci 68(20):3359-3375. doi: 10.1007/s00018-011-0750-2
35. Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Gotz J (2010) Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 10(8):1621-1633. doi: 10.1002/pmic.200900651
36. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Drose S, Brandt U, Savaskan E, Czech C, Götz J, Eckert A (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A 106(47):20057-20062. doi: 10.1073/pnas.0905529106
37. Pagani L, Eckert A (2011) Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011:925050. doi: 10.4061/2011/925050
38. Swerdlow RH (2011) Brain aging, Alzheimer's disease, and mitochondria. Biochim Biophys Acta 1812(12):1630-1639. doi: 10.1016/j.bbadis.2011.08.012
39. Nicholls DG, Darley-Usmar VM, Wu M, Jensen PB, Rogers GW, Ferrick DA (2010) Bioenergetic profile experiment using C2C12 myoblast cells. J Vis Exp. doi: 10.3791/2511
40. Vasconsuelo A, Milanesi L, Boland R (2013) Actions of 17beta-estradiol and testosterone in the mitochondria and their implications in aging. Ageing Res Rev 12(4):907-917. doi: 10.1016/j.arr.2013.09.001
41. Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J (2008) Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 149(6):3167-3175. doi: 10.1210/en.2007-1227
42. Vest RS, Pike CJ (2013) Gender, sex steroid hormones, and Alzheimer's disease. Horm Behav 63(2):301-307. doi: 10.1016/j.yhbeh.2012.04.006
43. Vina J, Borras C (2010) Women live longer than men: understanding molecular mechanisms offers opportunities to intervene by using estrogenic compounds. Antioxid Redox Signal 13(3):269-278. doi: 10.1089/ars.2009.2952
44. Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62(6):685-691. doi: 10.1001/archpsyc.62.6.685
45. Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019:24-28. doi: 10.1196/annals.1297.005
46. Schuessel K, Leutner S, Cairns NJ, Muller WE, Eckert A (2004) Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transm 111(9):1167-1182. doi: 10.1007/s00702-004-0156-5
47. Callahan MJ, Lipinski WJ, Bian F, Durham RA, Pack A, Walker LC (2001) Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 158(3):1173-1177
48. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T (2003) Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis 14(3):318-327
49. Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, Pike CJ (2010) Sex differences in beta-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res 1366:233-245. doi: 10.1016/j.brainres.2010.10.009
50. Yao J, Irwin R, Chen S, Hamilton R, Cadenas E, Brinton RD (2012) Ovarian hormone loss induces bioenergetic deficits and mitochondrial beta-amyloid. Neurobiol Aging 33(8):1507-1521. doi: 10.1016/j.neurobiolaging.2011.03.001
51. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106(34):14670-14675. doi: 10.1073/pnas.0903563106
52. Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, Pike CJ (2007) Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci 27(48):13357-13365. doi: 10.1523/JNEUROSCI.2718-07.2007
53. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87(2):589-598. doi: 10.1210/jcem.87.2.8201
54. Pike CJ, Carroll JC, Rosario ER, Barron AM (2009) Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 30(2):239-258. doi: 10.1016/j.yfrne.2009.04.015
55. Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ (2011) Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 32(4):604-613. doi: 10.1016/j.neurobiolaging.2009.04.008
56. Rosario ER, Carroll J, Pike CJ (2010) Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res 1359:281-290. doi: 10.1016/j.brainres.2010.08.068
57. Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ (2006) Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci 26(51):13384-13389. doi: 10.1523/JNEUROSCI.2514-06.2006
58. Papasozomenos SC (1997) The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease. Proc Natl Acad Sci USA 94(13):6612-6617
59. Boeve BF, Hutton M (2008) Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol 65(4):460-464. doi: 10.1001/archneur.65.4.460
60. Siuda J, Fujioka S, Wszolek ZK (2014) Parkinsonian syndrome in familial frontotemporal dementia. Parkinsonism Relat Disord 20(9):957-964. doi: 10.1016/j.parkreldis.2014.06.004
61. Dumont M, Stack C, Elipenahli C, Jainuddin S, Gerges M, Starkova NN, Yang L, Starkov AA, Beal F (2011) Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. FASEB J 25(11):4063-4072. doi: 10.1096/fj.11-186650
62. Liu XA, Zhu LQ, Zhang Q, Shi HR, Wang SH, Wang Q, Wang JZ (2008) Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A. Neurochem Res 33(9):1811-1820. doi: 10.1007/s11064-008-9638-4
63. Alvarez-de-la-Rosa M, Silva I, Nilsen J, Perez MM, Garcia-Segura LM, Avila J, Naftolin F (2005) Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann N Y Acad Sci 1052:210-224. doi: 10.1196/annals.1347.016
64. Amtul Z, Wang L, Westaway D, Rozmahel RF (2010) Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease. Neuroscience 169(2):781-786. doi: 10.1016/j.neuroscience.2010.05.031
65. Morinaga A, Hirohata M, Ono K, Yamada M (2007) Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fibrils in vitro. Biochem Biophys Res Commun 359(3):697-702. doi: 10.1016/j.bbrc.2007.05.158
66. Magnaghi V, Cavarretta I, Galbiati M, Martini L, Melcangi RC (2001) Neuroactive steroids and peripheral myelin proteins. Brain Res Brain Res Rev 37(1-3):360-371
67. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R (2005) Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A 102(52):19198-19203. doi: 10.1073/pnas.0505203102
68. Jayaraman A, Carroll JC, Morgan TE, Lin S, Zhao L, Arimoto JM, Murphy MP, Beckett TL, Finch CE, Brinton RD, Pike CJ (2012) 17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology 153(11):5467-5479. doi: 10.1210/en.2012-1464
69. Overk CR, Perez SE, Ma C, Taves MD, Soma KK, Mufson EJ (2013) Sex steroid levels and AD-like pathology in 3xTgAD mice. J Neuroendocrinol 25(2):131-144. doi: 10.1111/j.1365-2826.2012.02374.x
70. Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, Taddei K, Villemagne VL, Martins RN, Group AR (2014) Associations between gonadotropins, testosterone and beta amyloid in men at risk of Alzheimer's disease. Mol Psychiatry 19(1):69-75. doi: 10.1038/mp.2012.147
71. Barron AM, Garcia-Segura LM, Caruso D, Jayaraman A, Lee JW, Melcangi RC, Pike CJ (2013) Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J Neurosci 33(20):8891-8897. doi: 10.1523/JNEUROSCI.1350-13.2013
72. Bixo M, Backstrom T, Winblad B, Andersson A (1995) Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 55(3-4):297-303
73. Asih PR, Wahjoepramono EJ, Aniwiyanti V, Wijaya LK, Ruyck K, Taddei K, Fuller SJ, Sohrabi H, Dhaliwal SS, Verdile G, Carruthers M, Martins RN (2015) Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. CNS Neurol Disord Drug Targets 14(5):576-586
74. Rocca WA, Grossardt BR, Shuster LT (2014) Oophorectomy, estrogen, and dementia: a 2014 update. Mol Cell Endocrinol 389(1-2):7-12. doi: 10.1016/j.mce.2014.01.020